The short answer
PD-L1 TPS is a biomarker result. It means a tumor proportion score for PD-L1 staining. In some cancers, biomarker results can help guide targeted therapy, immunotherapy, or clinical trial options, but the result only matters in context.
PD-L1 TPS is a biomarker or molecular result, not a treatment decision by itself.
It can be relevant in some lung cancer immunotherapy decisions.
A positive result may or may not change treatment depending on cancer type, stage, prior treatment, and available options.
Ask whether the result is from tumor testing, blood testing, inherited genetic testing, or another method.
Choose how you want to understand this
The full explanation.
The short answer
TPS stands for tumor proportion score. It is the percentage of cancer cells that stain positive for a protein called PD-L1. This is measured out of all the cancer cells the pathologist looks at. Unlike CPS, TPS counts only the cancer cells themselves. It does not count the immune cells nearby. It is reported as a percentage, from 0 to 100. Doctors use it mainly in non-small cell lung cancer.
Where it may be relevant
TPS can matter in some lung cancer immunotherapy decisions. Not everyone with lung cancer needs, or benefits from, the same testing or treatment.
Why it can affect treatment options
PD-L1 is part of how cancer cells switch off nearby immune attack. So a higher TPS suggests immunotherapy is more likely to help on its own. In advanced non-small cell lung cancer, a higher TPS is one of the things that makes immunotherapy without chemotherapy worth considering, and it is one of the eligibility criteria written into some approvals. It is not the decision. Histology, stage, how fast the disease is moving, how well you are, whether a targetable gene change was found, other illnesses that make immunotherapy risky, which regimen is being proposed, and which laboratory assay produced the number all feed in as well.
Assays are not interchangeable either. A TPS from one approved test does not necessarily translate to another, so the percentage on your report belongs with the test that produced it.
Two things are worth knowing. First, this result speaks to immunotherapy, not targeted therapy. Second, where a targetable gene change such as EGFR or ALK is found, that result generally leads the treatment decision rather than the TPS, whatever the percentage. Which treatment follows depends on the exact variant and on current approvals.
What this result does NOT tell you
A low TPS does not rule immunotherapy out. Many immunotherapy combinations pair a checkpoint inhibitor with chemotherapy. These are approved regardless of PD-L1 level. So people with TPS below 1% still have immunotherapy options in most cases. TPS also does not predict your individual response with certainty. It shifts the odds across a group of people. It does not decide any one person's outcome. TPS results can also vary by lab. Different antibody tests, called clones, can give different scores on the same tissue. A score is tied to the specific assay that produced it. It is not interchangeable with a result from a different one.
Is this urgent?
A TPS result itself is not an emergency. It is one input your oncology team weighs. They combine it with your stage, other biomarker results, and your overall health, to build a treatment plan. This usually happens before your first round of systemic treatment begins.
Questions to ask
Ask what your exact TPS score is, and which assay produced it. Ask whether pembrolizumab alone, or in combination with chemotherapy, is being recommended, and why. Ask whether your tumor has also been tested for EGFR, ALK, and other biomarkers — those results can take priority over TPS. Ask what the plan is if your TPS is low.
Sources
Words to know
Tap any term to see what it means.
Common questions
What is PD-L1 TPS?
PD-L1 TPS means a tumor proportion score for PD-L1 staining. It is one type of result that may appear on a biomarker, molecular, genomic, or pathology report.
Can it affect treatment?
Sometimes. Certain biomarkers can point toward targeted therapy, immunotherapy, or a clinical trial, but the same result can mean different things in different cancers.
What should I ask my oncologist?
Ask whether the result is actionable for your cancer, whether a matched treatment exists, and whether a trial is relevant.
Questions to ask your doctor
Being prepared helps you get the most out of your appointments. Save or print these questions.
Tap a question to save it to your list (kept on this device).
Your next step
Look up more plain-language explanations for report wording.
Speak With Trained Specialists & Human Navigators
Cancer Explained provides educational guidance, but does not replace trained specialists, social workers, or your medical team.
Talk to a trained cancer information specialist
Free, confidential assistance from NCI Cancer Information Service via phone, chat, or email.
Contact your oncology team
Locate after-hours contact numbers, portal messages, or urgent triage phone lines.
Find a patient navigator
Get one-on-one help with appointments, logistics, translation, and care coordination.
Find a genetic counselor
Discuss inherited mutation risk, family history, and genetic testing options.
Find an oncology social worker
Access emotional counseling, family support groups, and mental health resources.
Find a financial navigator
Locate copay assistance foundations, grant programs, and lodging/travel support.
Find a clinical-trial specialist
Search matching studies and speak with NCI trial information specialists.
Get urgent help
Immediate emergency guidance for fever (>100.4°F during chemo), severe pain, or shortness of breath.
Help Us Improve This Guide
Did this explanation answer your question and help you determine your next step?
Know someone who needs this?
Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.
Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.
Knowledge Check
0 of 3 answered
This self-assessment checks understanding of educational content only. It is not medical advice.
Plain-language explanation of the published sources cited on this page. AI-assisted, source-checked, not clinician-reviewed.
Sources last checked: 2026-07-30 what this meansLast updated: 2026-08-19Next planned review: 2027-07-30
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status — Editorial review complete. This page completed Cancer Explained's editorial checks (sources, safety, plain language, duplication). It has not been reviewed by a physician or other healthcare professional.
General education — varies by person. Answers genuinely differ between people. This page explains what commonly varies and points you to your care team for your situation.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status: Editorial review complete — This page completed Cancer Explained's editorial checks (sources, safety, plain language, duplication). It has not been reviewed by a physician or other healthcare professional.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
Read more about our editorial process, our use of AI, and our corrections policy.
Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.
After using this page, do you understand what to do next?
Anonymous — we only record the answer, never who gave it.
Related articles
Still have questions?
Educational answers, plain language
Free to print and share